outgoing Infinity Pharmaceuticals CEO Adelene Perkins and CMO Robert Ilaria
September 5, 2023 05:32 AM EDTUpdated 06:05 AM
People

Fall­out from failed MEI merg­er con­tin­ues as In­fin­i­ty's CEO, CMO ex­it

Reynald Castañeda

Deputy Editor

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

TRENDING NOW

Biotech stocks plunge and in­dus­try fig­ures left to won­der af­ter Prasad's FDA ap­point­ment

FDA picks con­tro­ver­sial doc­tor Vinay Prasad as CBER di­rec­tor, in about-face from Marks

Live at 11 a.m.: What Vinay Prasad means for CBER, vac­cines, drug ap­provals and more

Sarep­ta’s stock plum­mets af­ter Prasad ap­point­ment, low Ele­v­idys sales

Marea heads to Phase 2b af­ter up­dat­ed bio­mark­er da­ta show CV drug’s promise

sponsored

In one of the riski­est in­dus­tries — Biotech — a sure­fire way to neu­tral­ize some of that risk emerges

A service from the Financial Times